Opthea Limited (OPT) - Research

$0.860 0.04 (4.88%)

OPT General Information +

ASX Code OPT
Website http://www.opthea.com
GICS Sub-Industry Biotechnology
Market Cap ($M) 214
Current Price $0.860
Day High $0.860
Day Low $0.825
Last Close $0.820
Price Movement $0.04 ( 4.88% )
Prices as at 16:40, 23 Jul 2019
+Security prices are delayed by at least 20 minutes and are indicative only.

OPT Company Overview

Business Description

Opthea Limited (OPT, formerly Circadian Technologies Limited) is a biologics drug developer focusing on ophthalmic disease therapies. Opthea's lead molecule is OPT-302 for the treatment of ‘back of the eye' disease such as wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). OPT-302 is a soluble form of VEGFR-3 that acts a VEGF-C/VEGF-D 'trap'.

OPT Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2020 F 0.00 -4.80 0.00% 0.00 0.00 0.00% 0.0%
2019 F 0.00 -9.50 0.00% 0.00 0.00 0.00% 0.0%
2018 A -16.90 -8.40 0.00% 0.00 0.00 0.00% 0.0%

OPT Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2018 A 2019 F 2020 F 2018 A 2019 F 2020 F 2018 A 2019 F 2020 F
CSL (CSL) $100,511M 0.3775 0.1512 0.1002 42.2576 36.7065 33.3629 1.39% 1.23% 1.37%
Clinuvel Pharmaceuticals (CUV) $1,606M 0.8671 0.0000 0.0000 122.8839 0.0000 0.0000 0.06% 0.00% 0.00%
Mesoblast (MSB) $743M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Opthea (OPT) $205M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

OPT Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 4.54 0.00
Market 0.67 14.90 1.18 1.05
Sector 1.46 80.10 3.53 3.29

OPT Directors

Name Position Start Date
Dr Megan Baldwin Chief Executive Officer, Managing Director 24 Feb 2014
Mr Geoffrey Paul Kempler Non-Executive Chairman, Non-Executive Director 30 Nov 2015
Mr Michael Sistenich Non-Executive Director 30 Nov 2015

OPT Management

Name Position
Michael Tonroe Chief Financial Officer,Company Secretary

OPT Substantial Shareholders

Holding Name
32,488,784 (16.02%) BVF Partners LP
18,936,079 (9.34%) Regal Funds Management Pty Limited
16,385,959 (8.08%) Baker Bros Advisors LP

OPT Calendar of Events

Date Event
24 February 2020 Report (Interim)
27 August 2019 Report (Annual)
27 August 2019 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.